NewGenIvf Group Ltd (NIVF) - Dilution Analysis

F-1 filing: This F-1 filing from NewGenIvf Group Limited relates to a proposed best-efforts public offering of Class A ordinary shares and warrants.

F-1 filing: This F-1 filing from NEWGENIVF GROUP LIMITED relates to the resale of 50,000,000 Class A Ordinary Shares by selling securityholders, including shares issuable to White Lion Capital LLC under a Common Stock Purchase Agreement and shares underlying convertible notes and warrants issued to JAK Opportunities VI LLC under various Securities Purchase Agreements.

20-F filing | 1.1M shares outstanding

F-1 filing: This F-1 filing is for the registration of resale of Class A Ordinary Shares by selling securityholders, including shares issued for the acquisition of MicroSort technology, shares issued to A SPAC Holdings Group Corp for consulting services, shares issuable upon conversion of notes and exercise of warrants, and shares that may be issued to White Lion Capital, LLC pursuant to a Common Stock Purchase Agreement.

F-1 filing: This prospectus relates to the resale by the selling shareholder identified in this prospectus (\"Selling Shareholder\") of up to 40,000,000 Class A Ordinary Shares, no par value per share (\"Ordinary Shares\") issuable by the Company to White Lion Capital, LLC (\"White Lion\") in connection with the Common Stock Purchase Agreement dated as of November 21, 2024, by and between the Company and White Lion (the \"White Lion Purchase Agreement\") (the \"Resale Shares\").

F-1 filing: Registration statement for resale of up to 5,912,281 Class A ordinary shares by selling shareholders.

20-F filing | 3.7M shares outstanding